Crossmark

Rethinking the combination treatment of fulvestrant and anastrozole for metastatic breast cancer: an integrated reanalysis of aromatase–estrogen receptor axis

Crossref DOI link: https://doi.org/10.1186/s40169-019-0246-5

Published Online: 2019-11-18

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Huang, Xing https://orcid.org/0000-0002-8886-2777
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (31970696, 81502975)

National Natural Science Foundation of China (31970696, 81502975)
License Information

Version of Record valid from 2019-11-18

Text and Data Mining valid from 2019-11-18
More Information

Article History

Received: 7 September 2019

Accepted: 22 October 2019

First Online: 18 November 2019

Ethics approval and consent to participate

: Not applicable.

: Not applicable.

: The author declares no competing interests.

Document is current

Any future updates will be listed below